Novel Therapies in Phase II and III Trials for Malignant Pleural Mesothelioma

Journal of the National Comprehensive Cancer Network : JNCCN - United States
doi 10.6004/jnccn.2012.0007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Harborside Press, LLC

Related search

Emerging Therapies for Malignant Pleural Mesothelioma

Current Respiratory Care Reports
2012English

Brief Report: A Phase II Study of Sunitinib in Malignant Pleural Mesothelioma. The NCIC Clinical Trials Group

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2011English

Malignant Pleural Mesothelioma and the Role of Non– Operative Therapies

2013English

Phase II Study of Cediranib in Patients With Malignant Pleural Mesothelioma: SWOG S0509

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2011English

Malignant Pleural Mesothelioma

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2009English

P1.09-011 LUME-Meso Phase II/III Study: Nintedanib + Pemetrexed/Cisplatin in Chemo-Naïve Patients With Malignant Pleural Mesothelioma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Heterogeneity in Malignant Pleural Mesothelioma

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

Malignant Cells From Pleural Fluids in Malignant Mesothelioma Patients Reveal Novel Mutations

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2018English

Gli as a Novel Therapeutic Target in Malignant Pleural Mesothelioma

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy